Surrozen, Inc.
SRZN- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001824893
In the last 90 days, Surrozen, Inc. insiders filed 0 open-market purchases and 1 sale; 70 institutions reported holding it in 13F filings for Q2 2026, worth $314.5M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Surrozen, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 32
- +4 vs. Q3 2021
- Shares held
- 23.9M
- +3.06M (+14.7%) vs. Q3 2021
- Total value
- $153.5M
- +$7.91M (+5.4%) vs. Q3 2021
- New holders
- 8
- 8 more added
- Sold out
- 4
- 5 more reduced
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SRZN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 70 | $314.5M |
| Q1 2026 | 59 | $314.2M |
| Q4 2025 | 55 | $195.1M |
| Q3 2025 | 36 | $81.7M |
| Q2 2025 | 31 | $53.9M |
| Q1 2025 | 30 | $63.5M |
| Q4 2024 | 24 | $35.4M |
| Q3 2024 | 23 | $25.5M |
| Q2 2024 | 21 | $23.1M |
| Q1 2024 | 16 | $15.0M |
| Q4 2023 | 17 | $9.78M |
| Q3 2023 | 25 | $7.90M |
| Q2 2023 | 22 | $8.62M |
| Q1 2023 | 23 | $9.91M |
| Q4 2022 | 26 | $9.36M |
| Q3 2022 | 27 | $44.1M |
| Q2 2022 | 24 | $63.1M |
| Q1 2022 | 30 | $67.4M |
| Q4 2021 | 32 | $153.5M |
| Q3 2021 | 29 | $150.7M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Surrozen, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of America Corp | 5 | $0 | 0.00% | +5 | New |
| Wells Fargo & Company | 139 | $1.00K | 0.00% | +6+4.5% | Added |
| Morgan Stanley | 82 | $1.00K | 0.00% | +82 | New |
| Private Capital Group, LLC | 300 | $2.00K | 0.00% | +300 | New |
| Penserra Capital Management LLC | 4,487 | $28.0K | 0.00% | +4,487 | New |
| Wolverine Asset Management LLC | 9,172 | $59.0K | 0.00% | +7,553+466.5% | Added |
| Citadel Advisors LLC | 11,442 | $74.0K | 0.00% | +11,442 | New |
| Millennium Management LLC | 12,600 | $81.0K | 0.00% | +12,600 | New |
| BlackRock Inc. | 36,199 | $233.0K | 0.00% | +1,240+3.5% | Added |
| Northern Trust Corp | 37,988 | $245.0K | 0.00% | 00.0% | Unchanged |
| Jasper Ridge Partners, L.P. | 46,838 | $302.0K | 0.01% | 00.0% | Unchanged |
| Nan Fung Group Holdings Ltd | 65,070 | $419.0K | 0.12% | +65,070 | New |
| State Street Corp | 67,300 | $433.0K | 0.00% | 00.0% | Unchanged |
| Prelude Capital Management, LLC | 73,843 | $476.0K | 0.02% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 156,719 | $1.01M | 0.00% | +28,180+21.9% | Added |
| Hudson Bay Capital Management LP | 195,400 | $1.26M | 0.01% | −104,600−34.9% | Reduced |
| Boxer Capital, LLC | 200,000 | $1.29M | 0.05% | 00.0% | Unchanged |
| Samsara BioCapital, LLC | 300,000 | $1.93M | 0.38% | 00.0% | Unchanged |
| Monashee Investment Management LLC | 350,000 | $2.25M | 0.56% | −150,000−30.0% | Reduced |
| Alyeska Investment Group, L.P. | 396,728 | $2.56M | 0.03% | −103,272−20.7% | Reduced |
| Perceptive Advisors LLC | 413,446 | $2.66M | 0.04% | −86,554−17.3% | Reduced |
| Laurion Capital Management LP | 520,000 | $3.35M | 0.06% | +150,000+40.5% | Added |
| Empery Asset Management, LP | 580,700 | $3.74M | 7.81% | +580,700 | New |
| Vanguard Group Inc | 629,685 | $4.05M | 0.00% | +8,447+1.4% | Added |
| Bridger Management, LLC | 700,001 | $4.51M | 0.58% | 00.0% | Unchanged |
| Euclidean Capital LLC | 802,964 | $5.17M | 2.94% | −10.0% | Reduced |
| Board of Trustees of The Leland Stanford Junior University | 806,374 | $5.19M | 0.33% | 00.0% | Unchanged |
| Harvard Management Co Inc | 826,852 | $5.33M | 0.50% | 00.0% | Unchanged |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 1,200,000 | $7.73M | 0.12% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 2,500,000 | $16.1M | 0.08% | 00.0% | Unchanged |
| Consonance Capital Management LP | 3,497,500 | $22.4M | 14.58% | +2,497,500+249.8% | Added |
| The Column Group LLC | 9,414,795 | $60.6M | 8.25% | +166,666+1.8% | Added |
| Virtu Financial LLC | 0 | $0 | 0.00% | −22,462−100.0% | Sold out |
| Highbridge Capital Management LLC | 0 | $0 | 0.00% | −11,701−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −417−100.0% | Sold out |
| DuPont Capital Management Corp | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Trustees of Columbia University in the City of New York | – | – | – | – | Not filed |